Medical News

RSS

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today.

24 Nov 2022

Single-cell transcriptome analysis provides insights into bat immunity

In a world first, scientists at Duke-NUS Medical School and colleagues in Singapore have sequenced the response to viral infection in colony-bred cave nectar bats (Eonycteris spelaea) at single-cell resolution.

24 Nov 2022

Study: Nearly 1 in 7 Americans regularly experience bloating issues

Nearly 1 in 7 Americans experience bloating on a weekly basis, and most aren't seeking professional care for it, according to a new study led by Cedars-Sinai investigators.

24 Nov 2022

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Researchers assessed the association between receiving a prescription for Paxlovid and COVID-19-related hospitalization in the ensuing 30 days.

24 Nov 2022

Sino Biological announces construction of its new US-based center for bioprocessing

Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext, which provides biological research reagents and related technical contract research services, is pleased to announce the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing at its Levit Green facility in Houston, Texas USA.

From Sino Biological Inc. 24 Nov 2022

Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

Patients with inflammatory bowel diseases (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

23 Nov 2022

COVID-19 disparities more likely to negatively impact Black and Hispanic men

More than two years into the pandemic, multiple analyses of federal, state and local data show that people of color were, and continue to be, disproportionately impacted by COVID-19.

23 Nov 2022

Study finds profound stigmas experienced by people living with Long Covid

The majority of people living with Long Covid experience some form of stigma directly related to their condition, according to a new study published in the journal PLOS ONE.

23 Nov 2022

New study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

23 Nov 2022

Young people treated for sleep disorders with benzodiazepines may be at higher risk of overdose

Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers.

23 Nov 2022

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

James Smyth, associate professor at the Fralin Biomedical Research Institute at VTC, has been awarded a five-year, $2.7 million grant from the National Institutes of Health to discover why viruses that normally infect our lungs can turn deadly when they infect the heart.

23 Nov 2022

Study shows link between vaping and risk of caries

A vaping habit could end up leading to a tarnished smile, and more frequent visits to the dentist.

23 Nov 2022

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

23 Nov 2022

Two studies reveal insights into how the spinal cord and brainstem contribute to sense of touch

The sense of touch is essential to almost everything we do, from routine tasks at home to navigating unfamiliar terrains that may conceal dangers.

23 Nov 2022

Morphine does not reduce worst breathlessness, study finds

Sometimes healthcare professionals treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps with severe chronic breathlessness.

23 Nov 2022

Study reveals structural insights into the elusive tankyrase protein that fuels bowel cancer

Scientists have revealed the inner workings of a key protein involved in a wide range of cellular processes – potentially paving the way for better and less toxic cancer drugs.

23 Nov 2022

COVID-19 vaccination provides 60% to 94% protection against reinfection

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant.

23 Nov 2022

Severe COVID-19 associated with an imbalance in key immune system signaling pathway

Researchers at the University of São Paulo in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.

23 Nov 2022

Vitamin D appears to have no substantial impact on statin-related muscle pain

Patients who take statins to lower high cholesterol levels often complain of muscle pains, which can lead them to stop taking the highly effective medication and put them at greater risk of heart attack or stroke.

23 Nov 2022

Single drug compound may offer a promising new strategy for treating prostate cancer patients

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

23 Nov 2022

Medical News

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Single-cell transcriptome analysis provides insights into bat immunity

Study: Nearly 1 in 7 Americans regularly experience bloating issues

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Sino Biological announces construction of its new US-based center for bioprocessing

Biologic therapy for IBD patients through a financial assistance program could have superior outcomes

COVID-19 disparities more likely to negatively impact Black and Hispanic men

Study finds profound stigmas experienced by people living with Long Covid

New study points to a strategy for inhibiting hyper-progression of melanoma

Young people treated for sleep disorders with benzodiazepines may be at higher risk of overdose

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

Study shows link between vaping and risk of caries

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

Two studies reveal insights into how the spinal cord and brainstem contribute to sense of touch

Morphine does not reduce worst breathlessness, study finds

Study reveals structural insights into the elusive tankyrase protein that fuels bowel cancer

COVID-19 vaccination provides 60% to 94% protection against reinfection

Severe COVID-19 associated with an imbalance in key immune system signaling pathway

Vitamin D appears to have no substantial impact on statin-related muscle pain

Single drug compound may offer a promising new strategy for treating prostate cancer patients

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News